All In Biotech

Drug Trial Radar · NCT04767529

A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Non-Cirrhotic Subjects With Nonalcoholic Steatohepatitis (NASH)

Last checked: Nov 19, 2026Latest source record: Jun 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 128 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

128

Actual

Start

Feb 16, 2021

Primary completion

May 2, 2024

Study completion May 2, 2024

Sponsor

Lead sponsor
Akero Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Feb 23, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in non-cirrhotic subjects with biopsy-proven F2 - F3 NASH.

Conditions

  • NASH - Nonalcoholic Steatohepatitis

Interventions

  • EfruxiferminDrug

    subcutaneous injection

  • PlaceboDrug

    subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effect of Efruxifermin (EFX) vs Placebo on Fibrosis Regression in Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)-Associated Stage 2 or 3 Fibrosis (F2 or F3)Time frame: 24 Weeks

Locations

55 sites in 2 countries. Site status is shown where the registry gives one.

  • Akero Clinical Study Site

    Chandler, Arizona

  • Akero Clinical Study Site

    Glendale, Arizona

  • Akero Clinical Study Site

    Tucson, Arizona

  • Akero Clinical Study Site

    North Little Rock, Arkansas

  • Akero Clinical Study Site

    Chula Vista, California

  • Akero Clinical Study Site

    Fresno, California

  • Akero Clinical Study Site

    La Jolla, California

  • Akero Clinical Study Site

    Los Angeles, California

  • Akero Clinical Study Site

    Los Angeles, California

  • Akero Clinical Study Site

    Los Angeles, California

  • Akero Clinical Study Site

    Orange, California

  • Akero Clinical Study Site

    Panorama City, California

  • Akero Clinical Study Site

    Rialto, California

  • Akero Clinical Study Site

    Santa Ana, California

  • Akero Clinical Study Site

    Fort Myers, Florida

  • Akero Clinical Study Site

    Inverness, Florida

  • Akero Clinical Study Site

    Lakewood Rch, Florida

  • Akero Clinical Study Site

    Miami, Florida

  • Akero Clinical Study Site

    Miami, Florida

  • Akero Clinical Study Site

    Miami Lakes, Florida

  • Akero Clinical Study Site

    Ocala, Florida

  • Akero Clinical Study Site

    Sarasota, Florida

  • Akero Clinical Study Site

    Marietta, Georgia

  • Akero Clinical Study Site

    Topeka, Kansas

  • Akero Clinical Study Site

    Baton Rouge, Louisiana

  • Akero Clinical Study Site

    Marrero, Louisiana

  • Akero Clinical Study Site

    Ypsilanti, Michigan

  • Akero Clinical Study Site

    Flowood, Mississippi

  • Akero Clinical Study Site

    Jackson, Mississippi

  • Akero Clinical Study Site

    Las Vegas, Nevada

  • Akero Clinical Study Site

    Charlotte, North Carolina

  • Akero Clinical Study Site

    Durham, North Carolina

  • Akero Clinical Study Site

    Morehead City, North Carolina

  • Akero Clinical Study Site

    Cincinnati, Ohio

  • Akero Clinical Study Site

    Greenville, South Carolina

  • Akero Clinical Study Site

    Hermitage, Tennessee

  • Akero Clinical Study Site

    Nashville, Tennessee

  • Akero Clinical Study Site

    Arlington, Texas

  • Akero Clinical Study Site

    Austin, Texas

  • Akero Clinical Study Site

    Cedar Park, Texas

Showing 40 of 55 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.